St. Louis Financial Planners Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
+19,202
New +$4.13M 2.67% 6
2026
Q1
Sell
-16,383
Closed -$3.74M 34
2025
Q4
$3.74M Buy
16,383
+1,753
+12% +$399K 2.3% 10
2025
Q3
$3.39M Buy
+14,630
New +$2.98M 2.18% 10
2024
Q3
Sell
-12,082
Closed -$2.06M 32
2024
Q2
$2.06M Sell
12,082
-1,104
-8% -$183K 1.77% 19
2024
Q1
$2.34M Sell
13,186
-205
-2% -$35.3K 2.1% 8
2023
Q4
$2.08M Buy
13,391
+1,712
+15% +$250K 1.93% 11
2023
Q3
$1.72M Sell
11,679
-889
-7% -$131K 1.38% 12
2023
Q2
$1.69M Buy
12,568
+1,350
+12% +$198K 1.7% 19
2023
Q1
$1.79M Buy
+11,218
New +$1.72M 2.03% 12

Other funds holding ABBV

St. Louis Financial Planners Asset Management's ABBV Position: Q2 2026 in Review

St. Louis Financial Planners Asset Management opened a new position in AbbVie (ABBV) in Q2 2026: 19,202 shares worth $5.01M. The stake represents 2.67% of the portfolio and ranks #6 among its holdings. This is a return to the name: St. Louis Financial Planners Asset Management previously reported a position in ABBV as recently as Q4 2025.

St. Louis Financial Planners Asset Management first reported a position in ABBV in Q1 2023 and has held it in 9 quarters since. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • St. Louis Financial Planners Asset Management held 19,202 shares of AbbVie worth $5.01M as of Q2 2026.
  • AbbVie was a new St. Louis Financial Planners Asset Management position in Q2 2026.
  • AbbVie made up 2.67% of St. Louis Financial Planners Asset Management's portfolio in Q2 2026, its #6 holding.
  • St. Louis Financial Planners Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 9 quarters since.
  • 2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on St. Louis Financial Planners Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.